Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
106M
-
Number of holders
-
93
-
Total 13F shares, excl. options
-
69.5M
-
Shares change
-
+3.02M
-
Total reported value, excl. options
-
$539M
-
Value change
-
+$23.7M
-
Put/Call ratio
-
0.13
-
Number of buys
-
51
-
Number of sells
-
-26
-
Price
-
$7.75
Significant Holders of Edgewise Therapeutics, Inc. - Common Stock (EWTX) as of Q2 2023
100 filings reported holding EWTX - Edgewise Therapeutics, Inc. - Common Stock as of Q2 2023.
Edgewise Therapeutics, Inc. - Common Stock (EWTX) has 93 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 69.5M shares
of 106M outstanding shares and own 65.65% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (14.6M shares), FMR LLC (7.36M shares), Novo Holdings A/S (6.07M shares), VIKING GLOBAL INVESTORS LP (5.94M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (3.93M shares), EcoR1 Capital, LLC (3.49M shares), BlackRock Inc. (3.13M shares), Cormorant Asset Management, LP (2.95M shares), Deep Track Capital, LP (2.75M shares), and CITADEL ADVISORS LLC (2.67M shares).
This table shows the top 93 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.